AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY. - Ana Isabel Rodríguez Pérez; María A Pedrosa; Carmen M Labandeira; Rita Valenzuela; Aloia Quijano; Mariña Sanchez-Andrade; Juan Antonio Suárez-Quintanilla; Jose Lanciego; José Luis Labandeira-García (IBRO Neuroscience Reports, 2023)